Two Different Regimens of Bemiparin as a Thromboprophylaxis in Morbidly Obese Surgical Patients
Status:
Not yet recruiting
Trial end date:
2025-04-02
Target enrollment:
Participant gender:
Summary
Morbid obesity, is known to be associated with a high risk of VTE and, unfortunately, fixed
doses of anticoagulant regimens may not provide optimal VTE prophylaxis in these patients
especially after surgery.